Homburger advises Addex Therapeutics on new PIPE transaction

Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, has completed a USD 4,2 million equity financing. The allosteric modulation company Addex has entered into a definitive agreement with Armistice Capital, a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 4,500,000 shares in the form of 750,000 American Depositary Shares (ADS) at a gross purchase price of USD 1.70 per ADS, which is equivalent to CHF 0.27 per share. Each ADS represents six shares. Additionally, Addex has agreed to issue to Armistice ordinary warrants to purchase up to 2,500,000 ADSs, as well as pre-funded warrants to purchase up to 1,750,000 ADSs in a concurrent private placement. The closing of the offering occurred on July 26, 2022.

The gross proceeds to Addex, before deducting offering expenses, are USD 4.2 million. Addex, based in Plan-les-Ouates, intends to use the net proceeds from this offering to advance its clinical and preclinical pipeline.

Homburger has advised Addex in this transaction. The team comprised partner Frank Gerhard (pictured left) and associate Romain Fakhoury (pictured right), both Corporate / M&A.

Homburger advises Addex Therapeutics on new PIPE transaction



Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram